SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 351 filers reported holding SAREPTA THERAPEUTICS INC in Q3 2019. The put-call ratio across all filers is 1.07 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $581,000 | -56.6% | 7,801 | -0.8% | 0.01% | -70.0% |
| Q4 2020 | $1,340,000 | +26.1% | 7,860 | +3.8% | 0.02% | +11.1% |
| Q3 2020 | $1,063,000 | -9.9% | 7,571 | +2.9% | 0.02% | -21.7% |
| Q2 2020 | $1,180,000 | +80.7% | 7,360 | +10.2% | 0.02% | +35.3% |
| Q1 2020 | $653,000 | -21.2% | 6,676 | +4.0% | 0.02% | -5.6% |
| Q4 2019 | $829,000 | +99.8% | 6,422 | +16.6% | 0.02% | +80.0% |
| Q3 2019 | $415,000 | – | 5,508 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ghost Tree Capital, LLC | 290,000 | $44,066,000 | 9.14% |
| Avoro Capital Advisors LLC | 1,400,000 | $212,730,000 | 7.35% |
| NEXTHERA CAPITAL LP | 50,317 | $7,646,000 | 6.37% |
| Eventide Asset Management | 1,123,000 | $170,640,000 | 5.19% |
| RTW INVESTMENTS, LP | 604,236 | $91,814,000 | 4.90% |
| Casdin Capital, LLC | 335,000 | $50,903,250,000 | 4.76% |
| Copernicus Capital Management, LLC | 30,000 | $4,559,000 | 4.06% |
| CADIAN CAPITAL MANAGEMENT, LP | 548,500 | $83,345,000 | 3.76% |
| Dynamic Capital Management Ltd | 4,677 | $711,000 | 3.54% |
| Camber Capital Management LP | 500,000 | $75,975,000 | 3.54% |